<DOC>
	<DOC>NCT02536404</DOC>
	<brief_summary>The purpose of this study is to determine whether APD334 is a safe and effective treatment for ulcerative colitis after 52 weeks of treatment.</brief_summary>
	<brief_title>Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients who completed the APD334003 study Patients who did not complete the APD334003 study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>